Cargando…

Genetics of migraine: where are we now?

Migraine is a complex brain disorder explained by the interaction of genetic and environmental factors. In monogenic migraines, including familial hemiplegic migraine and migraine with aura associated with hereditary small-vessel disorders, the identified genes code for proteins expressed in neurons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grangeon, Lou, Lange, Kristin Sophie, Waliszewska-Prosół, Marta, Onan, Dilara, Marschollek, Karol, Wiels, Wietse, Mikulenka, Petr, Farham, Fatemeh, Gollion, Cédric, Ducros, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940421/ https://www.ncbi.nlm.nih.gov/pubmed/36800925 http://dx.doi.org/10.1186/s10194-023-01547-8

Ejemplares similares

Future targets for migraine treatment beyond CGRP
por: Al-Hassany, Linda, et al.
Publicado: (2023)

The sense of stopping migraine prophylaxis
por: Al-Hassany, Linda, et al.
Publicado: (2023)

Primary headache epidemiology in children and adolescents: a systematic review and meta-analysis
por: Onofri, Agnese, et al.
Publicado: (2023)

The unusual course of a migraine attack during COVID-19 infection — Case studies of three patients
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2021)

Migraine and Sleep—An Unexplained Association?
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2021)

Unmet Needs in Preventive Treatment of Migraine
por: Bentivegna, Enrico, et al.
Publicado: (2023)

Debate: differences and similarities between tension-type headache and migraine
por: Onan, Dilara, et al.
Publicado: (2023)

Sinonasal symptoms in migraine without aura: results from the cross-sectional ‘Migraine in Poland’ study
por: Straburzynski, Marcin, et al.
Publicado: (2023)

Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort: Results from ‘Migraine in Poland’—a nationwide cross-sectional survey
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2023)

Does the Intensity of the Headache Differ According to the Level of Neck Disability in Chronic Migraine Patients?
por: Onan, Dilara, et al.
Publicado: (2022)

Reaching the Nadir of Medication Overuse in Chronic Migraine
por: Onan, Dilara, et al.
Publicado: (2022)

Cerebral Blood Flow and Other Predictors of Responsiveness to Erenumab and Fremanezumab in Migraine—A Real-Life Study
por: Nowaczewska, Magdalena, et al.
Publicado: (2022)

OnabotulinumtoxinA Treatment in Chronic Migraine: Investigation of Its Effects on Disability, Headache and Neck Pain Intensity
por: Onan, Dilara, et al.
Publicado: (2022)

The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence
por: Gollion, Cedric, et al.
Publicado: (2022)

Imaging the inflammatory phenotype in migraine
por: Christensen, Rune Häckert, et al.
Publicado: (2022)

Insular functional connectivity in migraine with aura
por: Gollion, Cédric, et al.
Publicado: (2022)

Cryptogenic Ischemic Stroke in Migraine: Role of Patent Foramen Ovale
por: Gollion, Cédric, et al.
Publicado: (2022)

Assessment of Visual and Brainstem Auditory Evoked Potentials in Patients with Hashimoto's Thyroiditis
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2021)

Hashimoto Encephalopathy—Still More Questions than Answers
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2022)

Where are we now?
Publicado: (1977)

Voices: Where are they now?
Publicado: (2023)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Bisphenol A: Where to Now?
por: Bucher, John R.
Publicado: (2009)

Social radiology: Where to now?
por: Ho, ELM
Publicado: (2012)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

What to do with non-responders to CGRP(r) monoclonal antibodies: switch to another or move to gepants?
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2023)

Where is Archives of Plastic Surgery Now? And Where is It Heading?
por: Kim, Jeong Tae
Publicado: (2014)

Cerebral Aneurysms Caused by Atrial Myxoma—A Systematic Review of the Literature
por: Chojdak-Łukasiewicz, Justyna, et al.
Publicado: (2022)

Mechanism of diabetic neuropathy: Where are we now and where to go?
por: Yagihashi, Soroku, et al.
Publicado: (2011)

Advances in digital CBT: where are we now, and where next?
por: Thew, Graham R., et al.
Publicado: (2022)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010)

Personal workstations: Where are we now?
por: Willers, Ian Malcolm
Publicado: (1982)

Human papillomavirus vaccination: where to now?
por: Garland, S M
Publicado: (2011)

Personal genomics: Where are we now?
por: Angrist, Misha
Publicado: (2016)

9. GFR - Where are We Now?
por: Delanghe, Joris R.
Publicado: (2009)

Calcaneal fractures: Where are we now?
por: Razik, Aisha, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0boscidb7k66ngbo3mkn7ek7vl